Prince Sattam bin Abdulaziz University or PSAU which includes Colleges of Medicine, Pharmacy and Applied Medical sciences has hired a Memorandum of Understanding (MoU) with GE Healthcare Partners to help improve the localized research and authorize Saudi students with the latest innovative technology. GE Healthcare General Manager Daoud Shinwari conveys says, “Through this they aim to cooperate on detailed research into healthcare-specific challenges that will ultimately enhance their overall efficiency.
According to a report submitted by the SClmago Journal & Country Rank, Egypt ranks 35 among 233 countries in academic paper submission in 2018, climbing 3 places compared to the previous year. The number of submissions by Egyptian researchers increased by 17.2 percent to record 22,018 submissions. Most of their academic paper submissions are in the fields of engineering sciences, medical sciences and chemistry. Moreover, Egypt is positioned among the top 10 percent of the countries in submissions in the fields of drug discovery, pharmaceuticals and toxins and treatments.
Plan S- a debated initiative to make all government-funded research to open access publishing- has been delayed from January 2020, by a year. COAlition S – the group of funders behind Plan S-has released updated guidelines which state that formal starting point of it mandates will now be January 2021. The revised guidelines were termed with the aim to give publishers additional time to adjust to the required changes and shift their business models. However, some researchers still argue that the delay does not give adequate time for the scientific community to adapt to the changes the bold plan requires.
Reference Link: https://www.nature.com/articles/d41586-019-01717-2
Elsevier has approved its first “read-and-publish” contract with a national consortium of universities and research institutions in Norway. The Norwegian consortium has employed an agreement that rolls the two costs into one, apart from paying distinctly to avail content behind paywalls and make the particular articles instantly available to the scientific community. This is a big deal because there are many librarians and speakers who trust this model will decrease subscription charges while improving open-access publications.
Members of the Jamaica Health Ministry and the University of the West Indies met with the University of Buffalo (UB) and SUNY faculty, to begin exploring ways to share research and clinical findings to help both countries. The meeting was focused on instituting a new center to study infectious diseases and engage in team science and collaborative research to achieve sustainable health in the Caribbean region. Though the center will be based in Jamaica, it will also have a presence in Buffalo, possibly at the UB Center of Excellence in Bioinformatics & Life Sciences.
Reference Link: http://www.buffalo.edu/news/releases/2019/04/012.html
The East African Science and Technology Commission or EASTECO has launched a local journal to promote research in science, technology and innovation. This is a step forward to improve sharing knowledge among the scientific community. The most interesting thing is that this is the first journal of its kind in the region. It is funded by six EAC states. EASTECO’s executive sectary, Gertrude Ngabirano said they aim new information which can be used to address issues disturbing the region. It will also help come up with evidence-based policies.
The New England Journal of Medicine or NEJM thinks open-access is not a good idea. An editorial published by Charlotte Haug, one of the correspondents of NEJM reports that the “experiment” has failed, and free access to scientific publications hasn’t delivered on its promises. NEJM is particularly concerned about “Plan S”, a plan in Europe that suggests that all scientists whose work is funded by the community be required to publish their results in open-access venues. Plan S is due to take upshot in 2020.
Future Drug Discovery is a peer-reviewed, open access journal covering the latest breakthrough science in drug discovery, research & development. Future Drug Discovery aims to harness high failure rates, presenting new advances and discussing their applications and translation in an openly accessible format, and providing a forum for discussing the field at large. It will be a quarterly publication publishing case histories, methodologies, original research, reviews and opinion articles covering the entire drug discovery pipeline, plus topics of interest to the drug discovery community. A comprehensive list of topics can be found at the journal webpage.
According to a study, scientists from pharmaceutical trade publish a higher fraction of their papers open access than academics who aren’t in industry. The open-access papers published by 23 large drug companies, such as Pfizer and Roche has overtaken the quantity of liberally available papers published most prominently in medicine-related fields.“It seems like big pharma has a notable niche in open access,” says Kyle Siler, a social scientist at Utrecht University in the Netherlands.
As a leader in the universal movement toward open access to publicly funded research, the University of California terminated its further subscriptions with Elsevier, the world’s largest scientific publisher. Despite months of bond negotiations, Elsevier was reluctant to meet UC’s key goal: acquiring universal open access to UC research to enable users to view it excluding any charges- as well as to restrain the rising costs associated with for-profit journals. Under Elsevier’s new proposed terms, the publisher would have charged UC authors large publication fees on top of the university’s multi-million dollar subscription, subsequently increasing the cost to the University and greater profits for Elsevier.